SEPP1 and DLEU2 expression levels were higher in patients with sarcopenia than in patients without sarcopenia, while the expression levels of GFOD1, GOT1, SV2A, and miR-181a were significantly lower in patients with sarcopenia than in patients without sarcopenia. Here, DLEU2 is linked to sarcopenia.